Article Information
History
- August 6, 2019.
Article Versions
- Version 1 (May 27, 2019 - 14:07).
- You are currently viewing Version 2 of this article (August 6, 2019 - 15:43).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Tim W McInerney1,
- Brian Fulton-Howard2,
- Christopher Patterson3,4,
- Devashi Paliwal1,
- Lars S Jermiin5,6,7,8,
- Hardip R Patel1,
- Judy Pa3,4,
- Russell H Swerdlow9,
- Alison Goate2,
- Simon Easteal1,
- Shea J Andrews2,*,
- for the Alzheimer’s Disease Neuroimaging Initiative†
- 1The John Curtin School of Medical Research, The Australian National University, Canberra, Australian Capital Territory, Australia
- 2Ronald M. Loeb Center for Alzheimer’s disease, Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York, USA
- 3Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
- 4Department of Neurology, Alzheimer’s Disease Research Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
- 5CSIRO Land & Water, Commonwealth Scientific Industrial & Research Organization, Acton, ACT 2601, Australia
- 6Research School of Biology, Australian National University, Canberra, ACT 2601, Australia
- 7School of Biology and Environmental Science, University College Dublin, Belfield, Dublin 4, Ireland
- 8Earth Institute, University College Dublin, Belfield, Dublin 4, Ireland
- 9Department of Neurology, Alzheimer’s Disease Center, University of Kansas, Fairway, KS, USA
- ↵*Correspondence to: Shea Andrews, The Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, USA. Tel: +1-212-659-8632; E-mail: shea.andrews{at}mssm.edu